ES514887A0 - Procedimiento para la preparacion de derivados de la piridazina. - Google Patents

Procedimiento para la preparacion de derivados de la piridazina.

Info

Publication number
ES514887A0
ES514887A0 ES514887A ES514887A ES514887A0 ES 514887 A0 ES514887 A0 ES 514887A0 ES 514887 A ES514887 A ES 514887A ES 514887 A ES514887 A ES 514887A ES 514887 A0 ES514887 A0 ES 514887A0
Authority
ES
Spain
Prior art keywords
piridazine
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES514887A
Other languages
English (en)
Other versions
ES8305736A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8305736A1 publication Critical patent/ES8305736A1/es
Publication of ES514887A0 publication Critical patent/ES514887A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES514887A 1981-08-11 1982-08-10 Procedimiento para la preparacion de derivados de la piridazina. Granted ES514887A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8115546A FR2511366A1 (fr) 1981-08-11 1981-08-11 Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (2)

Publication Number Publication Date
ES8305736A1 ES8305736A1 (es) 1983-04-16
ES514887A0 true ES514887A0 (es) 1983-04-16

Family

ID=9261385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514887A Granted ES514887A0 (es) 1981-08-11 1982-08-10 Procedimiento para la preparacion de derivados de la piridazina.

Country Status (30)

Country Link
US (1) US4710499A (es)
EP (1) EP0073161B1 (es)
JP (1) JPS5838263A (es)
KR (1) KR880002711B1 (es)
AR (1) AR231537A1 (es)
AT (1) ATE23042T1 (es)
AU (1) AU579570B2 (es)
CA (1) CA1179347A (es)
CS (1) CS239929B2 (es)
DD (1) DD202550A5 (es)
DE (1) DE3273893D1 (es)
DK (1) DK148596C (es)
EG (1) EG15749A (es)
ES (1) ES514887A0 (es)
FI (1) FI72970C (es)
FR (1) FR2511366A1 (es)
GR (1) GR76236B (es)
HU (1) HU189608B (es)
IE (1) IE53493B1 (es)
IL (1) IL66424A (es)
MA (1) MA19559A1 (es)
NO (1) NO158871C (es)
NZ (1) NZ201553A (es)
OA (1) OA07179A (es)
PH (1) PH18921A (es)
PL (1) PL137200B1 (es)
PT (1) PT75372B (es)
SU (1) SU1356960A3 (es)
YU (1) YU171682A (es)
ZA (1) ZA825515B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
JPS60218377A (ja) * 1984-04-16 1985-11-01 Mitsubishi Yuka Yakuhin Kk ４−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
DE69408598T2 (de) 1993-06-08 1998-09-17 Vertex Pharmaceuticals Inc Cam Pyridazine als Interleukin-1-beta Verwandlungsenzym Inhibitoren
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
ATE523199T1 (de) * 2004-11-02 2011-09-15 Univ Northwestern Pyridazinverbindungen und verfahren
EP1812408B1 (en) 2004-11-02 2013-10-09 Northwestern University Pyridazine compounds, compositions and methods
CA2650704A1 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
CA2650625A1 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
AU2008223066A1 (en) * 2007-03-02 2008-09-12 Northwestern University Compositions comprising derivatives of 3 -phenylpyridazine for treating seizure-related disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2473522A1 (fr) * 1980-01-16 1981-07-17 Synthelabo Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent

Also Published As

Publication number Publication date
MA19559A1 (fr) 1983-04-01
CS239929B2 (en) 1986-01-16
DK148596B (da) 1985-08-12
JPH0456032B2 (es) 1992-09-07
FI72970C (fi) 1987-08-10
IE53493B1 (en) 1988-11-23
AU8702982A (en) 1983-05-12
FI822768L (fi) 1983-02-11
PL237836A1 (en) 1983-02-28
ES8305736A1 (es) 1983-04-16
DK148596C (da) 1986-01-13
IL66424A0 (en) 1982-11-30
PH18921A (en) 1985-11-11
DE3273893D1 (en) 1986-11-27
US4710499A (en) 1987-12-01
NZ201553A (en) 1985-08-16
DD202550A5 (de) 1983-09-21
IE821822L (en) 1983-02-11
DK358782A (da) 1983-02-12
CA1179347A (en) 1984-12-11
ATE23042T1 (de) 1986-11-15
OA07179A (fr) 1984-04-30
NO158871B (no) 1988-08-01
NO158871C (no) 1988-11-09
KR880002711B1 (ko) 1988-12-26
FI822768A0 (fi) 1982-08-09
FR2511366B1 (es) 1984-12-14
IL66424A (en) 1985-10-31
ZA825515B (en) 1983-06-29
EP0073161B1 (fr) 1986-10-22
PT75372B (en) 1984-12-10
GR76236B (es) 1984-08-04
PL137200B1 (en) 1986-05-31
YU171682A (en) 1985-03-20
AR231537A1 (es) 1984-12-28
NO822717L (no) 1983-02-14
FR2511366A1 (fr) 1983-02-18
SU1356960A3 (ru) 1987-11-30
EP0073161A1 (fr) 1983-03-02
KR840001147A (ko) 1984-03-28
PT75372A (en) 1982-09-01
AU579570B2 (en) 1988-12-01
JPS5838263A (ja) 1983-03-05
FI72970B (fi) 1987-04-30
EG15749A (en) 1986-09-30
HU189608B (en) 1986-07-28

Similar Documents

Publication Publication Date Title
ES520180A0 (es) Procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2.
ES517167A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles sustituidos.
ES511955A0 (es) "procedimiento para la preparacion de derivados de cefem".
ES517757A0 (es) Procedimiento para la preparacion de derivados de benzazepina.
ES514795A0 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina.
ES521871A0 (es) Procedimiento para la preparacion de nuevos benzo-heterociclos.
ES524186A0 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
ES504791A0 (es) Procedimiento para la preparacion de derivados de caprolactama.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
ES538464A0 (es) Procedimiento para la preparacion de derivados de acilamida.
ES516864A0 (es) Procedimiento para la preparacion de derivados de penem.
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES517030A0 (es) Procedimiento para la preparacion de derivados de eburnamonina.
MX156087A (es) Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas
MX157777A (es) Procedimiento para la preparacion de derivados de ascoclorina
AR240460A1 (es) Procedimeitno para la preparacion de derivados de antraciclina.
ES518272A0 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES513619A0 (es) "procedimiento para la preparacion de derivados de 1-azolil-2-hidroxi-alcano".
ES517292A0 (es) Procedimiento para la preparacion de eteres 1-fenil-3-triazolil-vinilicos substituidos.
ES517288A0 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
ES513392A0 (es) Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos.
ES517153A0 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES518858A0 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401